CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Operating expenses:
Research and development	$ 3,603	$ 4,795	$ 12,520	$ 15,047
General and administrative	2,335	881	6,641	2,258
Total operating expenses	5,938	5,676	19,161	17,305
Loss from operations	(5,938)	(5,676)	(19,161)	(17,305)
Interest income	411	163	1,063	615
Other income, net			7,159
Net loss	$ (5,527)	$ (5,513)	$ (10,939)	$ (16,690)
Net loss per share attributable to common stockholders, Basic (in dollars per share)	$ (0.59)	$ (2.14)	$ (1.62)	$ (6.48)
Net loss per share attributable to common stockholders, Diluted (in dollars per share)	$ (0.59)	$ (2.14)	$ (2.5)	$ (6.48)
Weighted-average common shares outstanding, Basic (in shares)	9,377,079	2,574,767	6,757,955	2,574,054
Weighted-average common shares outstanding, Diluted (in shares)	9,377,079	2,574,767	7,244,785	2,574,054
Comprehensive loss:
Net income (loss)	$ (5,527)	$ (5,513)	$ (10,939)	$ (16,690)
Unrealized gain on short-term investments	20		7
Comprehensive loss	$ (5,507)	$ (5,513)	$ (10,932)	$ (16,690)